NCT06808802View on ClinicalTrials.gov

To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions

Healthy

Interventions

DRUG

Retatrutide

Administered subcutaneously (SC)

DRUG

Metoprolol

Administered orally

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT06808802 - To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants | Biotech Hunter | Biotech Hunter